These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 18379254

  • 1. Increased surface toll-like receptor 2 expression in superantigen shock.
    Hopkins PA, Pridmore AC, Ellmerich S, Fraser JD, Russell HH, Read RC, Sriskandan S.
    Crit Care Med; 2008 Apr; 36(4):1267-76. PubMed ID: 18379254
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
    Adib-Conquy M, Adrie C, Fitting C, Gattolliat O, Beyaert R, Cavaillon JM.
    Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
    [Abstract] [Full Text] [Related]

  • 3. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes.
    Kobayashi M, Yoshiki R, Sakabe J, Kabashima K, Nakamura M, Tokura Y.
    Br J Dermatol; 2009 Feb; 160(2):297-304. PubMed ID: 19016710
    [Abstract] [Full Text] [Related]

  • 4. Bacterial superantigens enhance the in vitro proinflammatory response and in vivo lethality of the TLR2 agonist bacterial lipoprotein.
    Kearney DE, Wang W, Redmond HP, Wang JH.
    J Immunol; 2011 Nov 15; 187(10):5363-9. PubMed ID: 22003201
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock.
    Salomao R, Brunialti MK, Gomes NE, Mendes ME, Diaz RS, Komninakis S, Machado FR, da Silva ID, Rigato O.
    Crit Care Med; 2009 Jan 15; 37(1):132-9. PubMed ID: 19050613
    [Abstract] [Full Text] [Related]

  • 6. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock.
    Pangault C, Le Tulzo Y, Tattevin P, Guilloux V, Bescher N, Drénou B.
    Crit Care Med; 2006 Apr 15; 34(4):1193-201. PubMed ID: 16484916
    [Abstract] [Full Text] [Related]

  • 7. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system.
    Lendemans S, Kreuzfelder E, Rani M, Bayeeh E, Schade FU, Flohé SB, Waydhas C, Flohé S.
    J Trauma; 2007 Oct 15; 63(4):740-6. PubMed ID: 18089999
    [Abstract] [Full Text] [Related]

  • 8. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans.
    Woehrle T, Du W, Goetz A, Hsu HY, Joos TO, Weiss M, Bauer U, Brueckner UB, Marion Schneider E.
    Cytokine; 2008 Mar 15; 41(3):322-9. PubMed ID: 18249133
    [Abstract] [Full Text] [Related]

  • 9. TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock.
    Brunialti MK, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, Salomao R.
    Shock; 2006 Apr 15; 25(4):351-7. PubMed ID: 16670636
    [Abstract] [Full Text] [Related]

  • 10. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis.
    Hasannejad H, Takahashi R, Kimishima M, Hayakawa K, Shiohara T.
    J Allergy Clin Immunol; 2007 Jul 15; 120(1):69-75. PubMed ID: 17531301
    [Abstract] [Full Text] [Related]

  • 11. Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism.
    Rahimpour R, Mitchell G, Khandaker MH, Kong C, Singh B, Xu L, Ochi A, Feldman RD, Pickering JG, Gill BM, Kelvin DJ.
    J Immunol; 1999 Feb 15; 162(4):2299-307. PubMed ID: 9973507
    [Abstract] [Full Text] [Related]

  • 12. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G, Levy R, Hillman D, Kaempfer R.
    Nat Med; 2000 Apr 15; 6(4):414-21. PubMed ID: 10742148
    [Abstract] [Full Text] [Related]

  • 13. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
    Tsujimoto H, Ono S, Majima T, Efron PA, Kinoshita M, Hiraide H, Moldawer LL, Mochizuki H.
    Clin Immunol; 2006 May 15; 119(2):180-7. PubMed ID: 16517212
    [Abstract] [Full Text] [Related]

  • 14. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G, Hillman D, Levy R, Kaempfer R.
    J Leukoc Biol; 2001 Jun 15; 69(6):921-7. PubMed ID: 11404377
    [Abstract] [Full Text] [Related]

  • 15. Superantigen recognition by HLA class II on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin.
    Hopkins PA, Fraser JD, Pridmore AC, Russell HH, Read RC, Sriskandan S.
    Blood; 2005 May 01; 105(9):3655-62. PubMed ID: 15644417
    [Abstract] [Full Text] [Related]

  • 16. Defense against biologic warfare with superantigen toxins.
    Kaempfer R, Arad G, Levy R, Hillman D.
    Isr Med Assoc J; 2002 Jul 01; 4(7):520-3. PubMed ID: 12120463
    [Abstract] [Full Text] [Related]

  • 17. Engagement of Toll-like receptors by mycoplasmal superantigen: downregulation of TLR2 by MAM/TLR4 interaction.
    Mu HH, Pennock ND, Humphreys J, Kirschning CJ, Cole BC.
    Cell Microbiol; 2005 Jun 01; 7(6):789-97. PubMed ID: 15888082
    [Abstract] [Full Text] [Related]

  • 18. Relationship between the expression of Toll-like receptor 2 and 4 in mononuclear cells and postoperative acute lung injury in orthotopic liver transplantation.
    Chi XJ, Cai J, Luo CF, Cheng N, Hei ZQ, Li SR, Luo GJ.
    Chin Med J (Engl); 2009 Apr 20; 122(8):895-9. PubMed ID: 19493410
    [Abstract] [Full Text] [Related]

  • 19. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J, Söderquist B, Normark BH, Norrby-Teglund A.
    Clin Infect Dis; 2004 Mar 15; 38(6):836-42. PubMed ID: 14999628
    [Abstract] [Full Text] [Related]

  • 20. The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
    Moore LJ, Pridmore AC, Dower SK, Read RC.
    J Antimicrob Chemother; 2004 Jul 15; 54(1):76-8. PubMed ID: 15190028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.